Literature DB >> 544937

Introduction of metastatic heterogeneity by short-term in vivo passage of a cloned transformed cell line.

J E Talmadge, J R Starkey, W C Davis, A L Cohen.   

Abstract

An experimental system for the study of metastasis has been developed using an epithelioid cell line of hepatic origin which had previously been chemically transformed in vitro. These metastatic cells were studied in the syngeneic rat strain. The cloned parent cell line metastasizes only to the lungs following intravenous, subcutaneous, or intraperitoneal injection. The metastatic phenotype is stable during in vitro passage, and subclones from the parent clone have a metastatic capacity statistically similar to that of the parent clone. Following ascites passage of the parent cell line, the cell population obtained exhibits the same metastatic ability as the parent clone. However, subclones obtained from the ascites-passaged population exhibit metastatic heterogeneity. This heterogeneity is introduced by the host passage and not by in vitro culture or subcloning. In the case of the two metastatic variants examined, the difference in the metastatic phenotype is found not to be due to differences in arrest or trapping of the cells but appears to be related to long-term survival and proliferation of the tumor cells following their arrest in the lungs. Morphologically the variants are very similar, and growth of the metastatic foci provokes a vigorous inflammatory response by the host.

Entities:  

Mesh:

Year:  1979        PMID: 544937     DOI: 10.1002/jss.400120208

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  15 in total

1.  Exogenously administered gangliosides fail to increase in vivo metastatic frequency or in vitro growth of murine neoplastic cells.

Authors:  L Facci; S D Skaper; D Presti; G Kirschner; A Leon; L Chieco-Bianchi
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

2.  Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin.

Authors:  S M Forrest; K W Ng; D M Findlay; V P Michelangeli; S A Livesey; N C Partridge; J D Zajac; T J Martin
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.

Authors:  V Pearce; S Pathak; D Mellard; D R Welch; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

6.  Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

7.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.

Authors:  G Poste; J Tzeng; J Doll; R Greig; D Rieman; I Zeidman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 9.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.